A recent consumer survey has highlighted significant gaps in prescription enforcement at retail pharmacies in Mumbai, even as the Maharashtra Food and Drug Administration intensified action against non-compliant drug licensees. According to the findings, 71 per cent of consumers in the city reported that chemists never or rarely refused to sell medicines without a doctor’s prescription, a higher proportion than the national average.
Key Findings from the Mumbai Survey
The LocalCircles survey, published in mid-September 2026, gathered responses from 3,697 consumers in Mumbai on their experiences with prescription checks. Of these respondents, 36 per cent stated that chemists never refused to provide medicines without a prescription, while another 35 per cent said such refusals occurred very rarely. Combined, these figures show that 71 per cent of those surveyed encountered little or no resistance when seeking prescription medicines without proper documentation.
Only a small minority reported stricter practices. Nine per cent said chemists refused sales without a prescription most of the time, and just five per cent said this happened always. The pattern was not limited to in-store purchases. Among respondents who ordered medicines for home delivery, a substantial share also reported that prescriptions were never or rarely demanded.
Nationally, the corresponding figure for consumers who said chemists never or rarely insisted on a prescription stood at 64 per cent. Mumbai’s higher percentage underscores that the challenge of enforcement is particularly pronounced in one of India’s densest urban pharmaceutical markets.
Regulatory Action by Maharashtra FDA
Parallel to the survey findings, the Maharashtra Food and Drug Administration reported substantial enforcement activity between June and August 2026. During this three-month period, the department inspected 2,902 drug establishments. Of these, 2,295 were sales establishments and 607 were manufacturing units.
Action was initiated against 880 licensees. This included the suspension of 677 licences and the cancellation of 203 licences. The majority of these actions — 740 out of 880 — involved retailers and wholesalers. In addition, the FDA conducted 104 search-and-seizure operations, resulting in the seizure of illegal drugs and cosmetics valued at ₹11.41 crore. Twenty FIRs were registered and 21 individuals were arrested.
Inspectors identified several recurring violations that align closely with the consumer experiences reflected in the survey. These included the sale and distribution of medicines without the direct supervision of a registered pharmacist, dispensing of prescription drugs without valid prescriptions, failure to maintain or update Schedule H1 registers, sales without proper invoices, and the presence of expired medicines in the saleable stock.
Why Prescription Compliance Matters
Prescription requirements exist primarily to protect patient safety. Many medicines, particularly those under Schedule H and Schedule H1, carry risks of side effects, drug interactions, antimicrobial resistance, or dependency when used without medical supervision. Antibiotics, for example, are frequently obtained without prescriptions, contributing to the broader public health challenge of antimicrobial resistance.
When chemists dispense such medicines freely, patients may self-medicate incorrectly, delay proper diagnosis, or use incomplete courses of treatment. The absence of a qualified pharmacist’s oversight further compounds the risk, as consumers may not receive essential counselling on dosage, duration, or potential contraindications.
The survey also pointed to limited access to qualified professional assistance at many outlets. Nationally, only about 31 per cent of consumers reported receiving help from a qualified pharmacist most of the time or always, while a notable minority said they were assisted by unqualified staff. These findings suggest that gaps exist not only in prescription verification but also in the professional supervision that retail pharmacy practice is expected to provide.
Structural Challenges in Enforcement
Several factors contribute to weak prescription compliance. High competition among neighbourhood chemists can create pressure to fulfil customer requests quickly rather than insist on documentation. Many consumers themselves prefer the convenience of obtaining familiar medicines without visiting a doctor, especially for recurring or perceived minor ailments. Home delivery and informal purchasing arrangements further reduce opportunities for verification.
Regulatory capacity is another constraint. While the Maharashtra FDA’s recent drive demonstrates that intensive inspection campaigns can identify and penalise violations, sustaining such oversight across thousands of retail outlets requires continuous resources and monitoring systems. Schedule H1 drugs, which mandate record-keeping and prescription retention, appear particularly vulnerable to incomplete compliance.
At the national level, the Union Health Ministry has proposed measures such as mandatory CCTV surveillance at medical stores dealing in prescription medicines. The intention is to create a stronger audit trail and deter non-compliant sales. Whether technological monitoring, combined with stricter licensing conditions and public awareness, can meaningfully shift behaviour remains to be tested in practice.
Consumer Behaviour and Systemic Risks
The survey data indicate that a large proportion of medicine purchases in Mumbai continue to occur through local chemists, reinforcing the central role of neighbourhood pharmacies in the healthcare supply chain. When these outlets routinely bypass prescription requirements, the cumulative public health impact can be significant. Inappropriate antibiotic use accelerates resistance. Misuse of other prescription drugs can lead to adverse reactions, treatment failure, or dependency.
Patients who obtain medicines without professional advice also lose the opportunity for early detection of more serious underlying conditions. What begins as a convenient purchase for symptomatic relief may mask the need for proper medical evaluation.
The Path Toward Stronger Compliance
Improving prescription discipline requires coordinated action on multiple fronts. Regulatory agencies need sustained inspection regimes rather than episodic drives, along with clear and consistently applied penalties. Pharmacy owners and staff require ongoing training and incentives to prioritise compliance over short-term sales. Consumers, too, need better awareness of the risks associated with unsupervised medicine use.
Technology can play a supporting role. Digital prescription systems, linked dispensing records, and surveillance tools may help create accountability. However, technology alone cannot substitute for the presence of qualified pharmacists and a culture of professional responsibility.
The Maharashtra FDA’s action against 880 licensees in three months shows that enforcement is possible and that violations are widespread enough to warrant serious attention. The Mumbai survey results, showing that 71 per cent of consumers rarely face prescription checks, illustrate why such enforcement remains necessary. Bridging the gap between regulatory standards and everyday retail practice is essential if the medicines supply chain is to protect rather than endanger public health.
Read more – todaybestoffers.info